Holen Sie sich die Stockscreener-App
358.16
0.54%
1.92
Handel nachbörslich:
360.00
1.84
+0.51%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SYK?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$356.24
Offen:
$356.6
24-Stunden-Volumen:
1.88M
Relative Volume:
1.40
Marktkapitalisierung:
$136.93B
Einnahmen:
$24.38B
Nettoeinkommen (Verlust:
$2.94B
KGV:
47.03
EPS:
7.6159
Netto-Cashflow:
$4.07B
1W Leistung:
-6.66%
1M Leistung:
-3.33%
6M Leistung:
-5.30%
1J Leistung:
-2.45%
1-Tages-Spanne:
$353.86
$360.65
1-Wochen-Bereich:
$353.86
$383.06
52-Wochen-Spanne:
$329.16
$406.19
Stryker Corp Stock (SYK) Company Profile
Firmenname
Stryker Corp
Sektor
Branche
Telefon
(269) 385-2600
Adresse
1941 STRYKER WAY, PORTAGE, MI
Vergleichen Sie SYK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
358.16 | 136.23B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
ABT
Abbott Laboratories
|
123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
MDT
Medtronic Plc
|
90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-18 | Eingeleitet | Rothschild & Co Redburn | Neutral |
| 2025-02-26 | Fortgesetzt | Citigroup | Buy |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-10 | Eingeleitet | Wolfe Research | Outperform |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-22 | Hochstufung | Needham | Hold → Buy |
| 2024-01-31 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-09-05 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-01-25 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2023-01-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-11-01 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-28 | Hochstufung | Edward Jones | Hold → Buy |
| 2022-07-21 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-07-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-13 | Eingeleitet | Truist | Hold |
| 2022-03-16 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-03-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-12-07 | Eingeleitet | Loop Capital | Buy |
| 2021-09-14 | Fortgesetzt | Raymond James | Mkt Perform |
| 2021-07-28 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2021-06-01 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Underweight |
| 2020-10-06 | Eingeleitet | Northland Capital | Market Perform |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-04-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-04-01 | Herabstufung | Goldman | Buy → Sell |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Hold |
| 2020-01-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-12-30 | Bestätigt | BTIG Research | Buy |
| 2019-11-05 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-10-30 | Bestätigt | BofA/Merrill | Buy |
| 2019-07-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-01-30 | Bestätigt | Canaccord Genuity | Buy |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2019-01-02 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-08-16 | Eingeleitet | BTIG Research | Buy |
| 2018-06-27 | Eingeleitet | Bernstein | Mkt Perform |
| 2018-04-27 | Bestätigt | Stifel | Buy |
Alle ansehen
Stryker Corp Aktie (SYK) Neueste Nachrichten
Truist Financial Maintains Stryker Corp(SYK.US) With Hold Rating, Maintains Target Price $392 - 富途牛牛
Stryker stock price target lowered to $450 from $455 at Bernstein - Investing.com
Is Stryker Corporation stock a dividend growth opportunityWeekly Earnings Recap & Daily Oversold Bounce Ideas - newser.com
Stryker Corporation $SYK Shares Sold by Welch & Forbes LLC - MarketBeat
TIAA Trust National Association Has $12.87 Million Holdings in Stryker Corporation $SYK - MarketBeat
Will Stryker Corporation stock remain a Wall Street favoriteWeekly Trend Report & Weekly Setup with ROI Potential - newser.com
United States Neurology Devices Market Research 2025-2033: Rising Neurological Disorder Prevalence, Advancements in Treatment Technologies, and Government R&D Support Spur Expansion - GlobeNewswire Inc.
What insider purchases suggest about Stryker Corporation (SYK) stock2025 Volume Leaders & Community Consensus Trade Signals - newser.com
Kesler Norman & Wride LLC Has $6.88 Million Stake in Stryker Corporation $SYK - MarketBeat
Leeward Financial Partners LLC Acquires Shares of 851 Stryker Corporation $SYK - MarketBeat
1,261 Shares in Stryker Corporation $SYK Purchased by AlphaStar Capital Management LLC - MarketBeat
Integrity Alliance LLC. Has $2.23 Million Stock Holdings in Stryker Corporation $SYK - MarketBeat
Will Stryker Corporation (SYK) stock outperform global peers2025 Key Highlights & Entry Point Confirmation Alerts - newser.com
Stryker (NYSE:SYK) Given New $405.00 Price Target at Evercore ISI - MarketBeat
Stryker Corporation (NYSE:SYK) Q3 2025 Earnings Call Transcript - Insider Monkey
A Quick Look at Today's Ratings for Stryker Corp(SYK.US), With a Forecast Between $405 to $440 - 富途牛牛
Stryker (NYSE:SYK) Price Target Raised to $410.00 - MarketBeat
GAM Holding AG Sells 1,813 Shares of Stryker Corporation $SYK - MarketBeat
Simon Quick Advisors LLC Grows Stock Holdings in Stryker Corporation $SYK - MarketBeat
Mesirow Financial Investment Management Inc. Increases Stock Holdings in Stryker Corporation $SYK - MarketBeat
Hantz Financial Services Inc. Sells 1,204 Shares of Stryker Corporation $SYK - MarketBeat
Key metrics from Stryker Corporation’s quarterly data2025 Historical Comparison & Long-Term Capital Growth Strategies - newser.com
Decoding Stryker Corp (SYK): A Strategic SWOT Insight - GuruFocus
Stryker Corp’s Earnings Call Highlights Robust Growth - TipRanks
Stryker (NYSE:SYK) Announces Earnings Results - MarketBeat
BTIG Maintains 'Buy' Rating for Stryker (SYK) and Raises Price T - GuruFocus
Stryker Corporation (SYK) Stock Forecasts - Yahoo! Finance Canada
Stryker Corporation (SYK) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Stryker Corp. stock underperforms Friday when compared to competitors - MarketWatch
Compared to Estimates, Stryker (SYK) Q3 Earnings: A Look at Key Metrics - Nasdaq
Stryker price target lowered to $405 from $410 at Evercore ISI - TipRanks
Evercore Maintains Stryker Corp(SYK.US) With Buy Rating, Cuts Target Price to $405 - 富途牛牛
Stifel Maintains Stryker Corp(SYK.US) With Buy Rating, Maintains Target Price $440 - 富途牛牛
STRYKER CORP SEC 10-Q Report - TradingView
SYK grows 10.3% in Q3 2025; $4.81B Inari deal, $3B notes - Stock Titan
A Quick Look at Today's Ratings for Stryker Corp(SYK.US), With a Forecast Between $410 to $453 - 富途牛牛
BLB&B Advisors LLC Trims Stake in Stryker Corporation $SYK - MarketBeat
Stryker Lifts Outlook After Topping Sales And Profit Estimates - Finimize
The Analyst Verdict: Stryker In The Eyes Of 7 Experts - Benzinga
Stryker stock price target raised to $410 from $408 at BTIG - Investing.com Philippines
Stryker Corp Reports Strong Q3 2025 Results - TipRanks
How Stryker Corporation stock performs in easing cyclesPortfolio Performance Summary & Safe Entry Trade Signal Reports - newser.com
Stryker Corp (SYK) Q3 2025 Earnings Call Highlights: Strong Organic Growth and Strategic ... - Yahoo Finance
Stryker Corp (SYK) Q3 2025 Earnings Call Highlights: Strong Orga - GuruFocus
Stryker: Q3 Earnings Snapshot - CTPost
Research Alert: Stryker Q3: Broad-based Acceleration Fuels Guidance Raise - 富途牛牛
Stryker (NYSE:SYK) Posts Q3 Sales In Line With Estimates - Barchart.com
Stryker Corp Q3 2025 Earnings: Revenue Surpasses Estimates at $6 - GuruFocus
Stryker earnings beat by $0.06, revenue topped estimates - Investing.com
Stryker Reports Third Quarter 2025 Operating Results - TradingView
[8-K] STRYKER CORP Reports Material Event | SYK SEC FilingForm 8-K - Stock Titan
Finanzdaten der Stryker Corp-Aktie (SYK)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.11%
0.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):